Patents by Inventor Isabelle Treilleux

Isabelle Treilleux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LKB1 AS PREDICTIVE MARKER OF EVEROLIMUS EFFICACY IN BREAST CANCER
    Publication number: 20150250770
    Abstract: Method for identifying a breast cancer likely to respond to treatment with everolimus comprising the following steps: Measuring the level of expression of the LKB 1 gene in a breast tumour sample previously taken from a breast cancer patient, Classifying the breast cancer as likely to respond to treatment with everolimus if the LKB1 gene is under-expressed in said breast tumour sample.
    Type: Application
    Filed: July 1, 2013
    Publication date: September 10, 2015
    Applicants: CENTRE LEON BERARD, UNIVERSITE CLAUDE BERNARD LYON 1, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
    Inventors: Isabelle Treilleux, Thomas Bachelot, Muriel Le Romancer-Cherifi
  • Detection of the ERalpha/Src/PI3K Complex as Predictive Marker in Breast Cancer
    Publication number: 20150212087
    Abstract: Detection of the ER?/Src/PI3K complex by a Proximity ligation assay as prognostic and theranostic marker in breast cancer.
    Type: Application
    Filed: July 26, 2013
    Publication date: July 30, 2015
    Inventors: Muriel Le Romancer-Cherifi, Olivier Tredan, Isabelle Treilleux